Article Details
Retrieved on: 2021-07-28 14:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The group's purchase of Affiris's Parkinson's portfolio comes after stumbles from Roche/Prothena and Biogen. Spotlight. Neuron with Lewy bodies ...
Article found on: www.evaluate.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here